Matches in SemOpenAlex for { <https://semopenalex.org/work/W4285593485> ?p ?o ?g. }
- W4285593485 endingPage "886" @default.
- W4285593485 startingPage "877" @default.
- W4285593485 abstract "Objective To assess the association between the use of sodium–glucose cotransporter 2 inhibitor (SGLT2i) and the incidence of diabetic retinopathy (DR).Research design and methods PubMed, Medline, Embase, the Cochrane Central Register of Controlled Trials, and Clinicaltrial.gov were searched from inception to October 2021. Randomized controlled trials (RCTs) with reports of incidence of DR and other eye disorders between SGLT2i and non-SGLT2i users with type 2 diabetes mellitus were included.Results In general, the incidences of DR were comparable between SGLT2i and non-SGLT2i users (OR = 0.80, 95%CI 0.61 to 1.06, P = 0.12). However, compared with non-SGLT2i users, the incidence of DR was significantly reduced in SGLT2i users with diabetes duration less than 10 years (OR = 0.32, 95%CI 0.13 to 0.76, P = 0.01). Weight reduction in SGLT2i users was associated with a decreased risk of retinal detachment. Moreover, longer study duration was associated with lower incidence of cataract and retinal vasculopathy in SGLT2i users.Conclusions In general, the use of SGLT2i was not associated with the incidence of DR. However, a reduced risk of DR was observed in SGLT2i users with diabetes duration less than 10 years. An early initiation of SGLT2i might be more likely to provide with ocular benefits." @default.
- W4285593485 created "2022-07-16" @default.
- W4285593485 creator A5007477169 @default.
- W4285593485 creator A5008962800 @default.
- W4285593485 creator A5018058348 @default.
- W4285593485 creator A5032967868 @default.
- W4285593485 creator A5037635622 @default.
- W4285593485 creator A5049710746 @default.
- W4285593485 creator A5058630240 @default.
- W4285593485 creator A5086973761 @default.
- W4285593485 date "2022-07-03" @default.
- W4285593485 modified "2023-10-18" @default.
- W4285593485 title "The association between the use of sodium glucose cotransporter 2 inhibitor and the risk of diabetic retinopathy and other eye disorders: a systematic review and meta-analysis" @default.
- W4285593485 cites W1503352903 @default.
- W4285593485 cites W1515680442 @default.
- W4285593485 cites W1526927233 @default.
- W4285593485 cites W1984461274 @default.
- W4285593485 cites W2004195654 @default.
- W4285593485 cites W2033428406 @default.
- W4285593485 cites W2047640394 @default.
- W4285593485 cites W2109689720 @default.
- W4285593485 cites W2127418688 @default.
- W4285593485 cites W2132827372 @default.
- W4285593485 cites W2138480916 @default.
- W4285593485 cites W2149505007 @default.
- W4285593485 cites W2158076638 @default.
- W4285593485 cites W2164800605 @default.
- W4285593485 cites W2219384223 @default.
- W4285593485 cites W2234307896 @default.
- W4285593485 cites W2262153647 @default.
- W4285593485 cites W2299779203 @default.
- W4285593485 cites W2333592484 @default.
- W4285593485 cites W2337454357 @default.
- W4285593485 cites W2424192521 @default.
- W4285593485 cites W2589252933 @default.
- W4285593485 cites W2590312224 @default.
- W4285593485 cites W2597545061 @default.
- W4285593485 cites W2624457286 @default.
- W4285593485 cites W2769264260 @default.
- W4285593485 cites W2789501881 @default.
- W4285593485 cites W2864383099 @default.
- W4285593485 cites W2884817413 @default.
- W4285593485 cites W2886019047 @default.
- W4285593485 cites W2891332575 @default.
- W4285593485 cites W2892498615 @default.
- W4285593485 cites W2911362510 @default.
- W4285593485 cites W2912656383 @default.
- W4285593485 cites W2939222610 @default.
- W4285593485 cites W2960325396 @default.
- W4285593485 cites W2981834443 @default.
- W4285593485 cites W3080857839 @default.
- W4285593485 cites W3087728590 @default.
- W4285593485 cites W3103168895 @default.
- W4285593485 cites W3120294371 @default.
- W4285593485 cites W3121608322 @default.
- W4285593485 cites W3136348503 @default.
- W4285593485 cites W3158522809 @default.
- W4285593485 cites W3181662563 @default.
- W4285593485 cites W3198570063 @default.
- W4285593485 cites W3198582157 @default.
- W4285593485 cites W3201421258 @default.
- W4285593485 cites W4200026682 @default.
- W4285593485 cites W4210269635 @default.
- W4285593485 cites W4211031298 @default.
- W4285593485 cites W4220868775 @default.
- W4285593485 cites W4229013070 @default.
- W4285593485 cites W4294233249 @default.
- W4285593485 doi "https://doi.org/10.1080/17512433.2022.2102973" @default.
- W4285593485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35839519" @default.
- W4285593485 hasPublicationYear "2022" @default.
- W4285593485 type Work @default.
- W4285593485 citedByCount "3" @default.
- W4285593485 countsByYear W42855934852022 @default.
- W4285593485 countsByYear W42855934852023 @default.
- W4285593485 crossrefType "journal-article" @default.
- W4285593485 hasAuthorship W4285593485A5007477169 @default.
- W4285593485 hasAuthorship W4285593485A5008962800 @default.
- W4285593485 hasAuthorship W4285593485A5018058348 @default.
- W4285593485 hasAuthorship W4285593485A5032967868 @default.
- W4285593485 hasAuthorship W4285593485A5037635622 @default.
- W4285593485 hasAuthorship W4285593485A5049710746 @default.
- W4285593485 hasAuthorship W4285593485A5058630240 @default.
- W4285593485 hasAuthorship W4285593485A5086973761 @default.
- W4285593485 hasConcept C120665830 @default.
- W4285593485 hasConcept C121332964 @default.
- W4285593485 hasConcept C126322002 @default.
- W4285593485 hasConcept C134018914 @default.
- W4285593485 hasConcept C168563851 @default.
- W4285593485 hasConcept C17744445 @default.
- W4285593485 hasConcept C199539241 @default.
- W4285593485 hasConcept C2777180221 @default.
- W4285593485 hasConcept C2778313320 @default.
- W4285593485 hasConcept C2779473830 @default.
- W4285593485 hasConcept C2779829184 @default.
- W4285593485 hasConcept C44249647 @default.
- W4285593485 hasConcept C555293320 @default.
- W4285593485 hasConcept C61511704 @default.
- W4285593485 hasConcept C71924100 @default.